期刊文献+

稳定型冠心病患者C反应蛋白的临床价值 被引量:1

The Clinical Value of CRP in Stable Coronary Heart Disease
下载PDF
导出
摘要 目的:探讨C反应蛋白(CRP)对稳定型冠心病患者的临床价值。方法:对46例经冠状动脉造影确诊的冠心病患者,排除急性冠脉综合征和急性心肌梗死,以血管狭窄≥50%作为诊断冠心病阳性标准。患者于入院次日查CRP,对CRP指标的判断采用我院正常值参考标准,分为正常与异常,即CRP≤8.2mg/L者均视为正常,>8.2mg/L均视为异常。结果:46例稳定型冠心病患者,按照病变累及的冠状动脉支数及病变狭窄程度两种分析方法,CRP均为正常。结论:CRP对稳定型冠心病的诊断,病变严重程度的判断无临床价值。 This paper aimed to investigate the diagnostic value of C -reaction protein (CRP) in coronary heart disease (CHD). 46 consecutive patients who underwent coronary angiography (CAG) were enrolled (excluxsion of acute coronary syndrome and myocardial infarction). The diagnostic standard of coronary heart disease is angiostenosis ≥50%. The blood tests of CRP were performed. Results of CRP were divided into normality and abnormality. The normality is CRP ≤ 8. 2mg/L, and abnormality is CRP 〉 8.2mg/L. According to the number of coronary artery pathological changes and severity Of angiostenosis, the results of CRP are normal in 46 patients with stable coronary heart disease. The clinical value of CRP is negative in diagnosing and estimating of angiostenosis in patient with stable coronary heart disease.
机构地区 楚雄州人民医院
出处 《楚雄师范学院学报》 2007年第3期27-28,40,共3页 Journal of Chuxiong Normal University
关键词 CRP 冠心病 冠状动脉造影 CRP CHD Coronary ang/ography.
  • 相关文献

参考文献2

二级参考文献47

  • 1Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Cireulation,2001,103 :1513-1315.
  • 2Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol, 2000,20 :2094-2099.
  • 3Li J J,Fang C H. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease. Med Hypotheses,2004,62:499-506.
  • 4Du Clos TW. Function of C-reactive protein. Ann Med, 2000,32 : 274-278.
  • 5Ferranti SD, Rifai N. C-reactive protein and cardiovascular disease:a review of risk prediction and interventions. Clin Chim Acta,2002 ,317 :1-15.
  • 6Li J J, Chen X J. Simvastatin inhibits interleukin45 release in human monocytes stimulated by C-reactive protein as well as lipopolysaccharide. Coren Artery Dis,2003,14:329-334.
  • 7Li J J,Fang C H,Chen MZ,et al. Rapid effects on lipid profile and C-reactive protein by simvastatin in patients with hypercholesterolemia.Clin Cardio1,2003 .26 :472-476.
  • 8Pascrei V, Willerson JT, Yeh ET. Direct pro-inflammatory effect of C-reactive protein on human endothelial cells. Circulation ,2000,102:2165-2168.
  • 9Pascrei V, Chang J, Willerson JT, et al. Modulation of C-reactive protein -mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atheresclerosis drugs. Circulation, 2001,103:2531-2534.
  • 10Zwaka TP, Hombach V, Torzewski J. C-reactive protein mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis. Circulation ,2001,103 : 1194-1197.

共引文献61

同被引文献23

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部